FDA Recalls Abbott Sensors Amid Investor Activity
What happened
The FDA classified a recall concerning sensors manufactured by Abbott Laboratories. Separately, reports indicate that Fisher Asset Management, which is associated with Fisher Investments, cut its stake in Abbott Laboratories by 33%.
From insidermonkey.com
Why it matters
Abbott Laboratories has experienced a decline of about 19% over the past year, driven by falling nutrition sales and fourth-quarter revenue missing expectations. The FDA regulates Abbott Laboratories' operations and product approvals.
From insidermonkey.com
Who's involved
- Abbott LaboratoriesGlobal health care and medical device products company facing a sensor recall
- FDARegulatory agency that oversees and sets operational standards for Abbott Laboratories
- Fisher InvestmentsInvestment firm that reduced its holdings in Abbott Laboratories
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Abbott LaboratoriesSpeculative
Abbott Laboratories might see its revenue and sales affected by the FDA's sensor recall classification.
Keep exploring
The entities involved
-
Abbott Laboratories
American global health care and medical device products company
- FDA